Insmed Balance Sheet
NASDAQ: INSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Insmed financial position
At the end of fiscal 2025, Insmed reported total assets of $2.26 billion, up 11.8% from a year earlier against total liabilities of $1.53 billion. Shareholders' equity stood at $739.0 million, or 32.6% of assets. The company held $510.4 million in cash and equivalents against $541.0 million of debt, a net debt position of $30.5 million.
The current ratio (current assets divided by current liabilities) was 3.83, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.73.
Summary generated from market data by MetaCap's automated system. Methodology
Insmed balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 510.44M | 555.03M | 482.37M | 1.07B | 716.78M | 532.76M | 487.43M | 495.07M | 381.17M | 162.59M |
| Short-Term Investments | 919.60M | 878.80M | 298.07M | 74.24M | 0 | — | — | — | — | — |
| Receivables | 140.86M | 52.01M | 41.19M | 29.71M | 24.35M | 16.56M | 19.23M | 5.51M | 0 | — |
| Inventory | 132.07M | 98.58M | 83.25M | 69.92M | 67.01M | 49.59M | 28.31M | 7.03M | 0 | — |
| Total Current Assets | 1.79B | 1.62B | 929.06M | 1.27B | 837.04M | 622.89M | 555.19M | 518.95M | 389.44M | 168.41M |
| Property, Plant & Equipment | 102.94M | 80.05M | 65.38M | 56.49M | 52.95M | 53.95M | 60.18M | 22.64M | 12.43M | 10.02M |
| Goodwill | 136.11M | 136.11M | 136.11M | 136.11M | 136.11M | 0 | — | — | — | — |
| Intangible Assets | 97.65M | 58.65M | 63.70M | 68.76M | 73.81M | 49.26M | 53.68M | 58.67M | 58.20M | — |
| Long-Term Investments | — | — | — | 0 | 50.04M | — | — | — | — | — |
| Total Assets | 2.26B | 2.03B | 1.33B | 1.66B | 1.24B | 796.15M | 742.30M | 604.56M | 462.05M | 237.96M |
| Accounts Payable | 79.91M | 73.03M | 65.39M | 50.46M | 35.78M | 42.85M | 13.18M | 17.74M | 14.67M | 10.44M |
| Short-Term Debt | — | — | 0 | — | — | — | — | — | 0 | — |
| Total Current Liabilities | 468.87M | 297.53M | 225.63M | 190.24M | 135.17M | 118.81M | 85.24M | 79.73M | 44.66M | 27.99M |
| Long-Term Debt | 540.96M | 1.10B | 1.16B | 1.13B | 566.59M | 356.32M | 335.94M | 316.56M | 55.57M | 54.79M |
| Total Liabilities | 1.53B | 1.74B | 1.66B | 1.57B | 833.04M | 520.27M | 480.63M | 396.29M | 100.99M | 83.47M |
| Shareholders' Equity | 738.98M | 285.38M | -331.92M | 87.95M | 410.47M | 275.88M | 261.67M | 208.27M | 361.06M | 154.48M |
| Retained Earnings | -5.64B | -4.36B | -3.45B | -2.70B | -2.27B | -1.83B | -1.54B | -1.28B | -957.88M | -765.24M |
| Total Debt | 540.96M | 1.10B | 1.16B | 1.13B | 566.59M | 356.32M | 335.94M | 316.56M | 55.57M | 54.79M |
| Net Cash (Debt) | 889.08M | 330.44M | -374.87M | 23.03M | 150.19M | 176.44M | 151.49M | 178.51M | 325.60M | 107.80M |
| Shares Outstanding | 214.26M | 179.38M | 147.98M | 135.65M | 118.74M | 102.76M | 89.68M | 77.31M | 76.61M | 62.02M |
This table shows 10 annual periods of Insmed's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow INSM's reporting calendar. What is a balance sheet?